Accelerated Cure Project for Multiple Sclerosis Announces Honorees

For Immediate Release
For more information contact:
Trish Gannon
Feinstein Kean Healthcare
Accelerated Cure Project for Multiple Sclerosis Announces Honorees
Nonprofit recognizes individuals who have made a major specific impact on accelerating the pace of Multiple Sclerosis (MS) research
(Waltham, MA October 13, 2010) -- Accelerated Cure Project for Multiple Sclerosis, a national nonprofit organization, today announced the names of the recipients who will be honored during the Second Annual "Opening Doors To Cure MS" recognition dinner.
The following awards will be presented on Saturday, October 23, 20010 at the Hyatt Boston Hotel, One Avenue De Lafayette.

2010 Distinguished Physician Award - Dr. Amit Bar-Or, MD, FRCP(C)

2010 Founders Award - Linda Kanner

2010 Water Cove Award - Colin Hill, CEO of Gene Network Sciences

These awards were established by Accelerated Cure Project to recognize individuals who have made a major specific impact on accelerating the pace of MS research through open access, participation, and collaboration.
Scientists have been trying to cure MS for many decades yet that door remains shut because, even now, very little is known about the factors underlying the disease. However, with our MS Repository samples, research database, and Cure Map, individuals affected by MS can now look forward to results and breakthroughs not previously possible.
About Accelerated Cure Project
Accelerated Cure Project for MS (ACP) is a nonprofit organization whose mission is to accelerate efforts toward a cure for multiple sclerosis (MS) by rapidly advancing research that determines its causes and mechanisms. We provide biomedical researchers with resources that catalyze open scientific collaboration and enable them to explore their novel research ideas rapidly and cost-efficiently. ACP’s strategic initiatives include the Multiple Sclerosis Discovery Forum and the ACP Repository, a large-scale collection of highly-characterized biosamples available to scientists at any organization conducting research that contributes to our mission. All results generated through analysis of Repository samples and data are contributed back to the ACP Repository Database, resulting in an increasingly valuable and comprehensive information resource that can be analyzed to reveal new insights about MS. To date, ACP has enrolled almost 3,000 participants into the Repository through a network of 10 MS clinical centers across the United States. The samples provided by people with MS and related disorders have supported more than 60 research studies worldwide and generated more than 150 million returned data points.
For more information about the Accelerated Cure Project or to make a corporate or individual donation, visit, or send an email to
About Multiple Sclerosis
Multiple Sclerosis is a chronic demyelinating disorder of the central nervous system that often results in severe disability including the inability to walk, blindness, cognitive dysfunction, extreme fatigue, and other serious symptoms. MS affects more than 400,000 people in the US and two million individuals worldwide. The disorder occurs twice as often in women as in men. What causes MS is undetermined and no cure has yet been developed.